You are here: Industry Insights > insomnia

News List

NDA for Lemborexant Submitted in the United States americanpharmaceuticalreview
January 16, 2019
Eisai and Purdue Pharma announced a new drug application has been submitted to the U.S. Food and Drug Administration (FDA) for lemborexant ....
PTSD Drug May Do More Harm Than Good drugs
December 28, 2018
A drug used to treat post-traumatic stress disorder (PTSD) may actually be harmful, a new study suggests.The high blood pressure drug prazosin is sometimes used to treat PTSD-related nightmares and insomnia that can increase suicide risk......
Alembic Pharma gets US FDA approval for insomnia treatment drug expressbpd
November 28, 2018
The approved abbreviated new drug application (ANDA) is the therapeutic equivalent to the reference listed drug product (RLD) Restoril Capsules
SleepCogni receives continued funding for insomnia research biospectrumasia
July 20, 2017
SleepCogni by integrating several scientifically, has founded treatments into a bedside personal medical device.
Sleepless Nights, Unhealthy Hearts? drugs
April 01, 2017
More worrisome news for people who toss and turn all night: Insomnia appears to be linked to a heightened risk for heart attack or stroke, a research review from China suggests.
Blake Insomnia Therapeutics enters a joint development with Sajo Consulting firstwordpharma
February 09, 2017
Blake Insomnia Therapeutics Inc. (OTCQB:BKIT) and Sajo Consulting LLC are pleased to announce entry into a Letter of Intent to provide joint development and commercialization of Zleepax™ in the treatment of insomnia.
Eisai acquires manufacturing rights for API from Roche to treat insomnia pharmaceutical-technology
January 19, 2017
Eisai has acquired the rights for manufacturing active pharmaceutical ingredients (API) for Japan from F Hoffman-La Roche for the insomnia treatment / anaesthesia induction agent flunitrazepam.

Previous page 1 2 Next page